Pricing of Marg ERP-Pharmaceutical Industry Software
Pricing plans
Introduce pricing plans
Simple, transparent pricing that grows with you. Try any plan free for 30 days.
Digilytics RevEl
USD 0.00 /
USD0.00
Perfect for your business requirements and platform usage.
BOOK A DEMO- Reduces non-value-added tasks
- Augments decision making
- Creates granular visibility of time to offer
- Easy to use
- can be plugged on to any loan origination system
- Reduces non-value-added tasks
- Augments decision making
- Creates granular visibility of time to offer
- Easy to use
- can be plugged on to any loan origination system
Key Specification
| Other Categories: | |
|---|---|
| Deployment: | Cloud Hosted |
| Customer Support: | Online (Ticket) |
| Customization: | No |
| Languages Support: | English |
Who uses Digilytics RevEl
Company Details
- Company Name: Digilytics RevEl
- Headquarter: london, London United Kingdom
Digilytics RevEl Description
Key Features & Specifications
- Audit Trail
- Compliance Management
- Workflow Management
- Chat (Messaging)
- e-Signature
- Client Management (Customer)
- Document Management
- Custom Workflows
- Mobile Access
- Collaboration
Digilytics RevEl Video
Alternative
More AlternativeKeka HR Payroll Platform Screenshots
User Reviews
WRITE A REVIEWKeka HR Payroll Platform Key Clients
Frequently asked questions
Everything you need to know about discovering, comparing, and choosing the right AI software for your business.
Digilytics RevEl has 1 plans,
- Digilytics RevEl USD 0.00
Digilytics RevEl is the Loan Origination Software used for the below functionalities.
Top 5 Digilytics RevEl features
- Audit Trail
- Compliance Management
- Workflow Management
- Chat (Messaging)
- e-Signature
Digilytics RevEl provides Online (Ticket) support.
Digilytics RevEl is not allowing Free Trial.
Digilytics RevEl provides Help Guides,Blogs,Video Guides for the software training.
Need Help Selecting
the Right AI Solution?
Speak with our team for tailored recommendations and insights to accelerate your AI adoption.